Fabian Gerlinghaus, CEO and co-founder of Cellares sat down with @nasdaq to discuss its innovative cell therapy manufacturing platform, the Cell Shuttle, which integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform delivering end-to-end automation. 🧬
Watch the full interview here: [ Ссылка ]
